The Food and Drug Administration (FDA) has approved Uzedy ® (risperidone extended-release injectable suspension) as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance ...

CTx-1301 is a novel proprietary formulation of dexmethylphenidate, a stimulant that increases norepinephrine and dopamine activity in the brain.

Afrezza is a rapid-acting inhaled human insulin that is currently approved to improve glycemic control in adults with diabetes mellitus.

Findings seen for adult patients followed for two years compared with those prescribed ibuprofen for low back pain.

The label update provides an option for patients who have received at least 1 approved systemic therapy if TNF blockers are clinically inadvisable.

The blood-based biomarker test measures Tau protein phosphorylated at threonine 181 in human plasma (pTau181).

Stable or declining mortality alongside increasing diagnoses for many cancers suggests that trend is due to increased detection.

65.2 percent of patients with sickle cell disease with vaso-occlusive crisis assigned to emergency severity index 3.

Rates of attrition up for male and female physicians, in rural and urban settings, across specialties, across geographic regions.

This month’s case resulted in a large monetary verdict against the physician, possibly a record-breaking sum in the New York country where it took place.

Giselle Mosnaim, MD, an allergist and immunologist at Endeavor Health, discusses Rhapsido® (remibrutinib), a new FDA-approved oral therapy for chronic ...

The approval was based on the C-POST study which evaluated cemiplimab in adults with CSCC at high risk of recurrence after surgery and radiation.